Work

Pharmacological and behavioral profile of N-[(3R)-1-azabicyclo[2.2.2]oct-3-yl]-6-chinolincarboxamide (EVP-5141), a novel α7 nicotinic acetylcholine receptor agonist/serotonin 5-HT3 receptor antagonist

Year: 2012

Type: article

Source: Psychopharmacology

DOI: 10.1007/s00213-012-2933-4

Authors: Frank G. Boess, Jean de Vry, Christina Erb, Timo Flessner, Martin Hendrix, Joachim Luithle, Christoph Methfessel, Katrin Schnizler, F. Josef van der Staay, Marja van Kampen, Welf-Burkhard Wiese, Gerhard König

Institutions: Eli Lilly (Germany), Bayer (Germany), Biotest (Germany), Universitätsklinikum Aachen, Utrecht University, UCB Pharma (Germany), FORUM Pharmaceuticals (United States)

Language: English

Topic: Nicotinic Acetylcholine Receptors Study

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Bayer HealthCare

OpenAlex ID: W1991367061

FWCI: 0.525

Cites: 70

Cited by: 18

Related to: 10